CGIM
Capital Group Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $591K | Sell |
12,145
-2,427
| -17% | -$118K | 0.11% | 129 |
|
|
2025
Q1 | $496K | Sell |
14,572
-13,126
| -47% | -$447K | 0.1% | 127 |
|
|
2024
Q4 | $1.09M | Buy |
27,698
+582
| +2% | +$22.9K | 0.21% | 100 |
|
|
2024
Q3 | $1.27M | Hold |
27,116
| – | – | 0.26% | 93 |
|
|
2024
Q2 | $1.46M | Buy |
27,116
+535
| +2% | +$28.9K | 0.32% | 78 |
|
|
2024
Q1 | $1.81M | Buy |
26,581
+6,485
| +32% | +$442K | 0.32% | 88 |
|
|
2023
Q4 | $1.26M | Sell |
20,096
-958
| -5% | -$60K | 0.13% | 136 |
|
|
2023
Q3 | $956K | Buy |
21,054
+533
| +3% | +$24.2K | 0.06% | 145 |
|
|
2023
Q2 | $1.15M | Hold |
20,521
| – | – | 0.06% | 143 |
|
|
2023
Q1 | $928K | Buy |
20,521
+646
| +3% | +$29.2K | 0.05% | 154 |
|
|
2022
Q4 | $808K | Buy |
+19,875
| New | +$808K | 0.03% | 164 |
|